000 | 01804 a2200505 4500 | ||
---|---|---|---|
005 | 20250515064025.0 | ||
264 | 0 | _c20070810 | |
008 | 200708s 0 0 eng d | ||
022 | _a1526-5900 | ||
024 | 7 |
_a10.1016/j.jpain.2007.02.429 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aFinkel, Julia C | |
245 | 0 | 0 |
_aKetamine as an adjuvant for treatment of cancer pain in children and adolescents. _h[electronic resource] |
260 |
_bThe journal of pain _cJun 2007 |
||
300 |
_a515-21 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural | ||
650 | 0 | 4 | _aAdolescent |
650 | 0 | 4 | _aAge Factors |
650 | 0 | 4 |
_aAnalgesics, Opioid _xadministration & dosage |
650 | 0 | 4 | _aChild |
650 | 0 | 4 | _aChild, Preschool |
650 | 0 | 4 | _aDose-Response Relationship, Drug |
650 | 0 | 4 | _aDrug Administration Schedule |
650 | 0 | 4 | _aDrug Synergism |
650 | 0 | 4 | _aDrug Therapy, Combination |
650 | 0 | 4 |
_aExcitatory Amino Acid Antagonists _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aHyperalgesia _xchemically induced |
650 | 0 | 4 | _aInjections, Intravenous |
650 | 0 | 4 |
_aKetamine _xadministration & dosage |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aNeoplasms _xcomplications |
650 | 0 | 4 |
_aPain Threshold _xdrug effects |
650 | 0 | 4 |
_aPain, Intractable _xdrug therapy |
650 | 0 | 4 | _aPatient Satisfaction |
650 | 0 | 4 |
_aQuality of Life _xpsychology |
650 | 0 | 4 |
_aReceptors, N-Methyl-D-Aspartate _xantagonists & inhibitors |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTreatment Outcome |
700 | 1 | _aPestieau, Sophie R | |
700 | 1 | _aQuezado, Zenaide M N | |
773 | 0 |
_tThe journal of pain _gvol. 8 _gno. 6 _gp. 515-21 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jpain.2007.02.429 _zAvailable from publisher's website |
999 |
_c16985381 _d16985381 |